In patent fight versus Pfizer generic, Astellas gets good news and bad kdunleavy Mon, 09/26/2022 – 14:14 More: In patent fight versus Pfizer generic, Astellas gets good news and bad Source: fierce
read moreLipocine seeks partner for midphase NASH asset in pivot to oral CNS drugs ntaylor Mon, 09/26/2022 – 10:13 More: Lipocine seeks partner for midphase NASH asset in pivot to oral CNS drugs Source: fierce
read moreSeeking sibling for Vyvgart, argenx files for FDA approval of subcutaneous efgartigimod ntaylor Mon, 09/26/2022 – 10:08 More: Seeking sibling for Vyvgart, argenx files for FDA approval of subcutaneous efgartigimod Source: fierce
read moreSatsuma peels off fresh strip of long-term migraine study data ahead of planned FDA filing ntaylor Mon, 09/26/2022 – 10:04 More: Satsuma peels off fresh strip of long-term migraine study data ahead of planned FDA filing Source: fierce
read moreDaiichi Sankyo bags an industry first with Japanese nod for blood cancer drug Ezharmia aliu Mon, 09/26/2022 – 09:54 More: Daiichi Sankyo bags an industry first with Japanese nod for blood cancer drug Ezharmia Source: fierce
read morePrecision X affinity ligand will enable the efficient purification of the non-Fc fusion protein More: Navigo and Mannin agree to develop a novel drug for treating COVID-19 Source: News
read more© 1994 - 2023 B.M. Pharmaceuticals